Century Therapeutics (NASDAQ:IPSC – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Monday. Get Century Therapeutics alerts:Check Out Our Latest Analysis on IPSCCentury Therapeutics Price PerformanceNASDAQ:IPSC opened at $0.57 on Monday. As a group, equities analysts anticipate that Century Therapeutics will post -1.61 earnings per share for the current fiscal year. Jane Street Group LLC purchased a new stake in Century Therapeutics during the 2nd quarter worth approximately $248,000. Featured StoriesReceive News & Ratings for Century Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Century Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.